Vaccine Collaboration Strategies in Asia
Novel Vaccine Development in Asia
New Technologies for Process Development
Achieving Operation and Quality Excellence
With the innovation in R&D, vaccine now is not only prophylactic but also therapeutic. In order to optimize vaccine R&D better, close cooperation among academic institutes, small biotechs, vaccine companies are necessary and efficient. Besides, strategic partnering in business development, R&D and manufacturing among global and local companies plays vital role in present global market development. New manufacturing technology and strict quality standard are undoubtedly enhancing the barrier in vaccine industry.
VacChina International 2013:
VacChina 2013 is the largest annual vaccine event gathering in China and covers the entire value chain of the vaccine industry. Here we will assess the latest industrial trends, R&D strategies, partnership models and manufacturing technology advancements in Asia, especially in Chinese vaccine market. Meanwhile, it will also highlight companies how to get into the important markets in Asia as well. Our aim is to promote global and regional partnership in business development, R&D and manufacturing, and assist local vaccine companies to find a feasible way to open the global market through this strategic brainstorming event.
Vaccine China International 2013
Conference –300+ executive level attendees from 10 countries and regions working within R&D strategy, Clinical, Partnering, Manufacturing, Quality Assurance etc
Technology – from Biotech, cell culture, virus removal, purification, single-use Tech etc on showcase
Seminars – 40+ eminent speakers with 60 seminars featuring technical and strategic topics
Posters - 100 posters from leading research institutes on showcase
Top Life Science VC/PE – 30+ Asian and global life science VC/PE looking for investment opportunities in China
One on One Partnering Meetings –60 prescheduled one to one business meetings